Immunocompromised state: Individuals with HIV, on immunosuppressive therapy for transplant or autoimmune disease, or with primary immunodeficiency should avoid Dihexa due to unknown immunological effects and cancer risk in this population
When used alongside other treatments, BPC-157s ability to stimulate growth factors and promote the regeneration of damaged tissues is enhanced
Final internal handling, preparation, storage logs, and acceptance procedures should always follow the receiving institutions own SOPs, quality systems, and compliance standards
That origin matters because BPC-157 has been studied not only for musculoskeletal repair, but also for gastrointestinal protection, gut barrier support, ulcer models, intestinal inflammation, and mucosal healing
It has been extensively studied in preclinical models for its regenerative and cytoprotective effects